Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials
2021 · Drug Safety · 30 citations
https://doi.org/10.1007/s40264-021-01076-w
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1
Papers
30
Citations
1
h-index
1
i10-index
Maribel Co-van der Mee is an academic researcher from GlaxoSmithKline (Belgium). The author has contributed to research in topics: Herpesvirus Infections and Treatments & Dermatology and Skin Diseases & Poxvirus research and outbreaks. The author has an h-index of 1, co-authored 1 publications.
Click to start Chat